Apr 25 |
Kenvue Inc. declares $0.20 dividend
|
Apr 22 |
WHO no longer planning safety alert on Kenvue cough syrup: report
|
Apr 20 |
J&J and Kenvue ordered to pay $45M in latest talc-related cancer claim
|
Apr 19 |
WHO considering safety alert on Kenvue kids cough syrup (update)
|
Apr 17 |
Kenvue: Fairly Valued Spinout
|
Apr 16 |
J&J CFO: We've 'beefed up' cardiovascular medical devices in hopes of reviving our medtech business
|
Apr 15 |
Wall Street Breakfast Podcast: Samsung Overtakes Apple As Top Smartphone Maker
|
Apr 11 |
Kenvue's performance has been 'woeful' with 'worst-in-class' growth - analyst
|
Apr 10 |
Johnson & Johnson cough syrup recalled in Nigeria over toxicity concerns
|
Apr 9 |
Kenvue cutting Neutrogena jobs, closing LA office - report
|